Legal & General Group
ONEM

Legal & General Group’s 1Life Healthcare ONEM Stock Holding History

Legal & General Group’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-136,048
Closed -$2.27M – 3415
2022
Q4 		$2.27M Sell
136,048
-1,772
-1% -$29.9K ﹤0.01% 1818
2022
Q3 		$2.36M Sell
137,820
-2,695
-2% -$42.3K ﹤0.01% 1780
2022
Q2 		$1.1M Buy
140,515
+35,475
+34% +$305K ﹤0.01% 2129
2022
Q1 		$1.16M Sell
105,040
-143,250
-58% -$1.6M ﹤0.01% 2195
2021
Q4 		$4.36M Buy
248,290
+37,398
+18% +$725K ﹤0.01% 1644
2021
Q3 		$4.27M Buy
210,892
+65,156
+45% +$1.67M ﹤0.01% 1639
2021
Q2 		$4.82M Buy
145,736
+30,507
+26% +$1.15M ﹤0.01% 1546
2021
Q1 		$4.5M Buy
115,229
+40,229
+54% +$1.89M ﹤0.01% 1614
2020
Q4 		$3.27M Buy
75,000
+11,631
+18% +$397K ﹤0.01% 1683
2020
Q3 		$1.8M Buy
63,369
+58,768
+1,277% +$1.86M ﹤0.01% 1806
2020
Q2 		$167K Sell
4,601
-16,927
-79% -$477K ﹤0.01% 2397
2020
Q1 		$390K Buy
+21,528
New +$472K ﹤0.01% 2137

Legal & General Group's ONEM Position: Q1 2023 in Review

Legal & General Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 136,048 shares — an estimated $2.27M sold.

Legal & General Group first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $4.82M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Legal & General Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Legal & General Group sold 136,048 1Life Healthcare shares in Q1 2023, an estimated $2.27M.
  • Legal & General Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Legal & General Group's 1Life Healthcare position peaked at $4.82M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Legal & General Group's 13F filing for Q1 2023, filed 15 May 2023.